Jump to navigation Jump to search
|Chemical and physical data|
|Molar mass||78.7 kg/mol g·mol−1|
This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued.
|This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.|